Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation.
Sergii TkachAndrii DorofeyevIurii KuzenkoNadiya BoykoTetyana FalalyeyevaLuigi BoccutoEmidio ScarpelliniNazarii KobyliakLudovico Montebianco AbenavoliPublished in: Medicina (Kaunas, Lithuania) (2022)
The intestinal microbiota plays an important role in maintaining human health, and its alteration is now associated with the development of various gastrointestinal (ulcerative colitis, irritable bowel syndrome, constipation, etc.) and extraintestinal diseases, such as cancer, metabolic syndrome, neuropsychiatric diseases. In this context, it is not surprising that gut microbiota modification methods may constitute a therapy whose potential has not yet been fully investigated. In this regard, the most interesting method is thought to be fecal microbiota transplantation, which consists of the simultaneous replacement of the intestinal microbiota of a sick recipient with fecal material from a healthy donor. This review summarizes the most interesting findings on the application of fecal microbiota transplantation in gastrointestinal and extraintestinal pathologies.
Keyphrases
- human health
- irritable bowel syndrome
- risk assessment
- metabolic syndrome
- ulcerative colitis
- cell therapy
- climate change
- papillary thyroid
- stem cells
- insulin resistance
- cardiovascular disease
- type diabetes
- young adults
- uric acid
- squamous cell
- high resolution
- bone marrow
- cardiovascular risk factors
- lymph node metastasis
- adipose tissue
- childhood cancer